170 related articles for article (PubMed ID: 16633081)
1. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of prior physical conditioning on relaxing response of corpus cavernosum from rats made hypertensive by nitric oxide inhibition.
Claudino MA; Priviero FB; Camargo EA; Teixeira CE; De Nucci G; Antunes E; Zanesco A
Int J Impot Res; 2007; 19(2):189-95. PubMed ID: 16915305
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
[TBL] [Abstract][Full Text] [Related]
4. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
5. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
6. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
Bernátová I; Pechánová O; Simko F
Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
[TBL] [Abstract][Full Text] [Related]
7. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
8. [The stereology of the myocardium in rats hypertensive due to the use of an inhibitor of nitric oxide synthesis].
Pereira LM; Mandarim-de-Lacerda CA
Rev Port Cardiol; 1997 Oct; 16(10):753-9, 743. PubMed ID: 9479938
[TBL] [Abstract][Full Text] [Related]
9. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats.
Afkir S; Nguelefack TB; Aziz M; Zoheir J; Cuisinaud G; Bnouham M; Mekhfi H; Legssyer A; Lahlou S; Ziyyat A
J Ethnopharmacol; 2008 Mar; 116(2):288-95. PubMed ID: 18191352
[TBL] [Abstract][Full Text] [Related]
10. Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertension.
Lantelme P; Lo M; Sassard J
J Hypertens; 1994 Jul; 12(7):791-5. PubMed ID: 7963507
[TBL] [Abstract][Full Text] [Related]
11. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
12. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Pechánová O; Bernátová I; Babál P
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
[TBL] [Abstract][Full Text] [Related]
13. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
14. Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.
Masuyama H; Tsuruda T; Sekita Y; Hatakeyama K; Imamura T; Kato J; Asada Y; Stasch JP; Kitamura K
Hypertens Res; 2009 Jul; 32(7):597-603. PubMed ID: 19424280
[TBL] [Abstract][Full Text] [Related]
15. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
16. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
18. Effect of aluminum on the blood-brain barrier permeability during nitric oxide-blockade-induced chronic hypertension in rats.
Kaya M; Kalayci R; Arican N; Küçük M; Elmas I
Biol Trace Elem Res; 2003 Jun; 92(3):221-30. PubMed ID: 12794274
[TBL] [Abstract][Full Text] [Related]
19. Ventricular hypertrophy and arterial hemodynamics following deprivation of nitric oxide in rats.
Hu CT; Chang HR; Hsu YH; Liu CJ; Chen HI
Life Sci; 2005 Nov; 78(2):164-73. PubMed ID: 16125730
[TBL] [Abstract][Full Text] [Related]
20. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
